Indication
Long Covid-19
8 clinical trials
11 products
1 drug
Clinical trial
The Effectiveness of Testofen on Energy, Fatigue, Mental Acuity, and Other Quality of Life Symptoms Post COVID-19 InfectionStatus: Recruiting, Estimated PCD: 2025-11-01
Product
TestofenProduct
Microcrystalline celluloseClinical trial
Digital Symptom Tracking and Wellness in Long COVID Patients Using Endourage Targeted Wellness Formula C™ Sublingual DropsStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
RECOVER-AUTONOMIC: A Platform Protocol for Evaluation of Interventions for Autonomic Dysfunction in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)Status: , Estimated PCD: 2025-12-01
Product
IVIGProduct
IVIG PlaceboProduct
IvabradineClinical trial
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)Status: , Estimated PCD: 2025-07-01
Product
PaxlovidProduct
Placebo ComparatorClinical trial
Examining the Utility of GLP-1 Agonists as Neuroprotective Agents Through a Pilot Clinical Trial in High Risk Population With Neurocognitive Deficits and ObesityStatus: Not yet recruiting, Estimated PCD: 2026-06-01
Product
LiraglutideClinical trial
Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)Status: Active (not recruiting), Estimated PCD: 2023-06-15
Product
Stellate Ganglion BlockClinical trial
RECOVER-AUTONOMIC (Ivabradine): Randomized Trial of the Effect of Ivabradine Versus Placebo on Long COVID SymptomsStatus: , Estimated PCD: 2025-12-01
Clinical trial
An Interventional, Double-Blinded, 2-Arm Study to Investigate the Efficacy of Orally Administered Nirmatrelvir/Ritonavir Compared With Placebo/Ritonavir in Non-hospitalized Adult Participants Suffering From Post-COVIDStatus: Recruiting, Estimated PCD: 2024-01-31
Product
Placebo/ritonavir